Seema A. Gulia

Mumbai, MH, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

Adenocarcinoma of Mammary Gland Type of the Vulva.

Adenocarcinoma of Mammary Gland Type of the Vulva.

Journal: International journal of surgical pathology
Published: April 07, 2026

Establishment and Molecular Characterization of a Short-Term Primary Culture Derived From Invasive Micropapillary Carcinoma of the Breast.

Establishment and Molecular Characterization of a Short-Term Primary Culture Derived From Invasive Micropapillary Carcinoma of the Breast.

Journal: Cell biology international
Published: January 02, 2026

Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial.

Addition of Carboplatin to Sequential Taxane-Anthracycline Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: A Phase III Randomized Controlled Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 20, 2025

Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: a prospective observational study.

Validation of Onco-MPI and Geriatric-8 for predicting 2-year mortality in older Indian patients with breast cancer: a prospective observational study.

Journal: Ecancermedicalscience
Published: August 09, 2025

NKX3.1 Expression in Male Breast Carcinoma: The Phantom Menace.

NKX3.1 Expression in Male Breast Carcinoma: The Phantom Menace.

Journal: International journal of surgical pathology
Published: July 07, 2025

Malignant Ovarian Germ Cell Tumor-Survival and Reproductive Outcomes and Patterns of Relapse.

Malignant Ovarian Germ Cell Tumor-Survival and Reproductive Outcomes and Patterns of Relapse.

Journal: Cancer medicine
Published: May 25, 2025

Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients.

Patient derived xenograft models of hormone receptor positive and HER2 negative breast cancer from Indian patients.

Journal: Scientific reports
Published: April 26, 2025

Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Retrospective Study to Determine Factors Influencing Outcome in Patients With Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Receiving Neoadjuvant Chemotherapy.

Journal: JCO global oncology
Published: April 23, 2025

Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer.

Combination chemotherapy and hormone therapy in patients with hormone receptor positive and HER2 negative metastatic breast cancer.

Journal: Scientific reports
Published: March 25, 2025

Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert Consensus.

Optimizing Premenopausal Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer Management in India: Insights From Expert Consensus.

Journal: Cureus
Published: December 24, 2024

Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in India.

Clinical profile and outcomes of young women with denovo-metastatic breast cancer: real-world data from a tertiary care centre in India.

Journal: Ecancermedicalscience
Published: November 17, 2024

Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer.

Genomic landscape of hormone therapy-resistant HR-positive, HER2-negative breast cancer.

Journal: Breast cancer research and treatment
Published: October 01, 2024
Showing 1-12 of 72

Last Updated: 09/26/2026